Title |
Gastric Adenocarcinoma: A Multimodal Approach
|
---|---|
Published in |
Frontiers in Surgery, August 2017
|
DOI | 10.3389/fsurg.2017.00042 |
Pubmed ID | |
Authors |
Humair S. Quadri, Brandon G. Smaglo, Shannon J. Morales, Anna Chloe Phillips, Aimee D. Martin, Walid M. Chalhoub, Nadim G. Haddad, Keith R. Unger, Angela D. Levy, Waddah B. Al-Refaie |
Abstract |
Despite its declining incidence, gastric cancer (GC) remains a leading cause of cancer-related deaths worldwide. A multimodal approach to GC is critical to ensure optimal patient outcomes. Pretherapy fine resolution contrast-enhanced cross-sectional imaging, endoscopic ultrasound and staging laparoscopy play an important role in patients with newly diagnosed ostensibly operable GC to avoid unnecessary non-therapeutic laparotomies. Currently, margin negative gastrectomy and adequate lymphadenectomy performed at high volume hospitals remain the backbone of GC treatment. Importantly, adequate GC surgery should be integrated in the setting of a multimodal treatment approach. Treatment for advanced GC continues to expand with the emergence of additional lines of systemic and targeted therapies. |
X Demographics
Geographical breakdown
Country | Count | As % |
---|---|---|
Switzerland | 1 | 100% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 1 | 100% |
Mendeley readers
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 53 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 7 | 13% |
Student > Bachelor | 7 | 13% |
Other | 5 | 9% |
Student > Postgraduate | 4 | 8% |
Student > Ph. D. Student | 3 | 6% |
Other | 11 | 21% |
Unknown | 16 | 30% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 21 | 40% |
Biochemistry, Genetics and Molecular Biology | 3 | 6% |
Nursing and Health Professions | 3 | 6% |
Agricultural and Biological Sciences | 3 | 6% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 4% |
Other | 3 | 6% |
Unknown | 18 | 34% |